Patents by Inventor Frank Mannuzza

Frank Mannuzza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050175705
    Abstract: A modified reconstituted extracellular matrix composition is provided herein. The composition includes an extracellular matrix and at least one exogenous component selected from heparin, fibronectin and laminin. The composition may have a basic pH. Additionally, provided herein is a cell culturing system including a substrate and a coating thereon of the composition to assess potential stimulators and/or inhibitors for their effects on various cell cultures while increasing the signal dynamic range.
    Type: Application
    Filed: December 13, 2004
    Publication date: August 11, 2005
    Inventors: Min Wu, Frank Mannuzza
  • Publication number: 20050079611
    Abstract: A modified reconstituted extracellular matrix composition is provided herein. The composition includes an extracellular matrix and at least one exogenous component selected from heparin, fibronectin and laminin. The composition may have a basic pH. Additionally, provided herein is a cell culturing system including a substrate and a coating thereon of the composition to assess potential stimulators and/or inhibitors for their effects on various cell cultures while increasing the signal dynamic range.
    Type: Application
    Filed: August 2, 2004
    Publication date: April 14, 2005
    Inventors: Min Wu, Frank Mannuzza
  • Patent number: 4129648
    Abstract: A high molecular weight extract of mammalian blood plasma and serum proteins of the group Cohn fraction IV, Cohn subfraction IV.sub.1, IV.sub.4 and haptoglobin, have been found to contain activity which inhibits endogenous prostaglandin synthetase. This extract is therefore of utility in treating or alleviating pathological conditions associated with excessive or unbalanced snythesis of endogenous prostaglandins, for example, in reducing bronchoconstriction or treating arthritis. For this purpose, the extract may be administered by injection, by inhalation, or topically.
    Type: Grant
    Filed: November 21, 1977
    Date of Patent: December 12, 1978
    Inventors: Harry O. J. Collier, Sheikh A. Saeed, Cyril Schneider, Frank Mannuzza